|
People and Investment :
About 5,000 scientists around the world are committed to
developing new healthcare solutions in crucial therapeutic areas.
In 2003 Taj Pharmaceuticals Pharmaceuticals invested more than
3,900 million Swiss francs (18.3 % of the divisional turnover) in
research and development.
Research Centres :
 |
|
Basel, Switzerland,Metabolic disorders, central nervous
system, vascular diseases
|
|
|
|
|
|
|
|
|
|
 |
|
Nutley, USA
Metabolic disorders, oncology, vascular diseases
|
|
|
|
|
|
|
|
|
|
 |
|
Palo
Alto, USA
Central nervous system, inflammatory diseases/bone,
genitourinary diseases, viral diseases
|
|
|
|
|
|
|
|
|
|
 |
|
Penzberg, Germany
Oncology
|
Technology Platforms :
Discovery chemistry
Synthesis and screening (ultra high throughput screening)
Combinatorial chemistry
Molecular modelling
Genetics, Genomics
Proteomics
Bioinformatics
|
Quality
